Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-06-16
DOI
10.1038/s41598-017-04406-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Therapeutics: A New Weapon in the War Against Cancer
- (2016) Nita Ahuja et al. Annual Review of Medicine
- Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential
- (2016) Anna Kazanets et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- HDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylases
- (2016) Ryan Lillico et al. Journal of Proteomics
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial
- (2015) John D. Hainsworth et al. CANCER
- Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines
- (2015) MD. ALI ASGAR et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
- (2015) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines – An Isobolographic Analysis
- (2015) Anna Wawruszak et al. PLoS One
- Epigenetic therapy for solid tumors: from bench science to clinical trials
- (2015) Yen-Yi Juo et al. Epigenomics
- Glycolytic metabolism influences global chromatin structure
- (2015) Xue-Song Liu et al. Oncotarget
- Epigenetic synergy between decitabine and platinum derivatives
- (2015) Taichun Qin et al. Clinical Epigenetics
- A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
- (2014) R M Glasspool et al. BRITISH JOURNAL OF CANCER
- Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA
- (2014) Ulrike Heinicke et al. CANCER LETTERS
- Looping Back to Leap Forward: Transcription Enters a New Era
- (2014) Michael Levine et al. CELL
- Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
- (2014) Jesús F San-Miguel et al. LANCET ONCOLOGY
- Pan-cancer patterns of DNA methylation
- (2014) Tania Witte et al. Genome Medicine
- NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)
- (2014) Luciana O. Almeida et al. FEBS Open Bio
- Genomic impact of transient low-dose decitabine treatment on primary AML cells
- (2013) J. M. Klco et al. BLOOD
- Mapping Human Epigenomes
- (2013) Chloe M. Rivera et al. CELL
- Chromatin Compaction Protects Genomic DNA from Radiation Damage
- (2013) Hideaki Takata et al. PLoS One
- The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines
- (2012) Min-Gyun Kim et al. Journal of Gynecologic Oncology
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Probing the Dynamics of Doxorubicin-DNA Intercalation during the Initial Activation of Apoptosis by Fluorescence Lifetime Imaging Microscopy (FLIM)
- (2012) Nai-Tzu Chen et al. PLoS One
- Oxidative Damage Targets Complexes Containing DNA Methyltransferases, SIRT1, and Polycomb Members to Promoter CpG Islands
- (2011) Heather M. O'Hagan et al. CANCER CELL
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors
- (2010) Flora Chik et al. CARCINOGENESIS
- A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
- (2010) Jaime Coronel et al. MEDICAL ONCOLOGY
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- Chromatin condensation modulates access and binding of nuclear proteins
- (2009) Robert M. Martin et al. FASEB JOURNAL
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer
- (2009) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- Chromatin structure influences the sensitivity of DNA to γ-radiation
- (2008) Martin Falk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Valproic acid resensitizes cisplatin-resistant ovarian cancer cells
- (2008) Ching-Tai Lin et al. CANCER SCIENCE
- DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells
- (2008) Hong Qiu et al. CANCER SCIENCE
- Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells
- (2008) K. K.W. To et al. MOLECULAR CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now